Oxford COVID Vaccine Trial Group
23  Ergebnisse:
Personensuche X
?
2

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222..:

Voysey, M ; Clemens, SAC ; Madhi, SA...
https://openaccess.sgul.ac.uk/id/eprint/112735/1/Safety%20and%20efficacy%20of%20the%20ChAdOx1%20nCoV-19%20vaccine%20%28AZD1222%29%20against%20SARS-CoV-2%20an%20interim%20analysis%20of%20four%20randomised%20contr.pdf.  , 2021
 
?
3

Single-dose administration and the influence of the timing ..:

Voysey, M ; Costa Clemens, SA ; Madhi, SA...
https://discovery.ucl.ac.uk/id/eprint/10123154/1/1-s2.0-S0140673621004323-main.pdf.  , 2021
 
?
5

Reactogenicity and immunogenicity after a late second dose ..:

Flaxman, A ; Marchevsky, NG ; Jenkin, D...
https://researchonline.ljmu.ac.uk/id/eprint/19049/1/Reactogenicity%20and%20immunogenicity%20after%20a%20late%20second%20dose%20or%20a%20third%20dose%20of%20ChAdOx1%20nCoV-19%20in%20the%20UK.pdf.  , 2021
 
?
6

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222..:

Voysey, Merryn ; Sprinz, Eduardo ; Stein, Ricardo...
The Lancet. London. Vol. 397, no. 10269 (2021), p. 881-891..  , 2021
 
?
7

Reactogenicity and immunogenicity after a late second dose ..:

Flaxman, Amy ; Marchevsky, Natalie G ; Jenkin, Daniel...
https://researchonline.lshtm.ac.uk/id/eprint/4663299/1/1-s2.0-S0140673621016998-main.pdf.  , 2021
 
?
8

Single-dose administration and the influence of the timing ..:

Voysey, M ; Costa Clemens, SA ; Madhi, SA...
https://openaccess.sgul.ac.uk/id/eprint/114167/1/1-s2.0-S0140673621004323-main.pdf.  , 2021
 
?
10

Correlates of protection against symptomatic and asymptomat..:

Feng, S ; Phillips, DJ ; White, T...
https://researchonline.ljmu.ac.uk/id/eprint/18987/1/Correlates%20of%20protection%20against%20symptomatic%20and%20asymptomatic%20SARS-CoV-2%20infection.pdf.  , 2021
 
?
11

Single-dose administration and the influence of the timing ..:

Voysey, Merryn ; Sprinz, Eduardo ; Stein, Ricardo...
The Lancet. London. Vol. 397, no. 10277 (2021), p. 881-891..  , 2021
 
?
13

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) ..:

Frater, J ; Ewer, KJ ; Ogbe, A...
https://researchonline.ljmu.ac.uk/id/eprint/19057/1/Safety%20and%20immunogenicity%20of%20the%20ChAdOx1%20nCoV-19%20%28AZD1222%29%20vaccine%20against%20SARS-CoV-2%20in%20HIV%20infection.pdf.  , 2021
 
?
14

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine ag..:

Folegatti, PM ; Ewer, KJ ; Aley, PK...
https://openaccess.sgul.ac.uk/id/eprint/112224/1/1-s2.0-S0140673620316044-main.pdf.  , 2020
 
1-15